AK

Ajay Kumar Bhalla

Active Director Director DIN 10276602
DIN 10276602 First appointment Aug 2023
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Ajay Kumar Bhalla

Data last updated:

Ajay Kumar Bhalla is a Director at Ervamine Pharma Private Limited (since 2023). Ervamine Pharma Private Limited reported revenue of ₹8,643 (FY 2025).

DIN 10276602
Primary Designation Director
First Appointment 11 Aug 2023
Oldest Company Age 3 yrs
Largest company Ervamine Pharma Private Limited · ₹8,643 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ervamine Pharma Private Limited U46497DL2023PTC418476
Director11 Aug 20232023₹8,643 (FY 2025)Active

Board colleagues of Ajay Kumar Bhalla

NameDINCompanyDesignation
Aaryan Bhalla10276603Ervamine Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ervamine Pharma Private Limited
Premium access

Shareholding and investment profile for Ajay Kumar Bhalla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ajay Kumar Bhalla

Ajay Kumar Bhalla currently holds 1 directorship: Ervamine Pharma Private Limited (Director, since 11 Aug 2023, revenue ₹8,643 (FY 2025)).

Ajay Kumar Bhalla was first appointed on 11 Aug 2023 as Director at Ervamine Pharma Private Limited.

The current boards of Ajay Kumar Bhalla's companies include Aaryan Bhalla (Ervamine Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available